Dexamethasone induces trabecular meshwork cell myofibroblast transdifferentiation through ARHGEF26
The FASEB Journal · 2024
DOI: 10.1096/fj.202400400rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Min Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Dexamethasone, Trabecular Meshwork, Cell Transdifferentiation, Myofibroblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Glucocorticoid use may cause elevated intraocular pressure, leading to the development of glucocorticoid‐induced glaucoma (GIG). However, the mechanism of GIG development remains incompletely understood. In this study, we subjected primary human trabecular meshwork cells (TMCs) and mice to dexamethasone treatment to mimic glucocorticoid exposure. The myofibroblast transdifferentiation of TMCs was observed in cellular and mouse models, as well as in human trabecular mesh specimens. This was demonstrated by the cytoskeletal reorganization, alterations in cell morphology, heightened transdifferentiation markers, increased extracellular matrix deposition, and cellular dysfunction. Knockdown of Rho guanine nucleotide exchange factor 26 (ARHGEF26) expression ameliorated dexamethasone‐induced changes in cell morphology and upregulation of myofibroblast markers, reversed dysfunction and extracellular matrix deposition in TMCs, and prevented the development of dexamethasone‐induced intraocular hypertension. And, this process may be related to the TGF‐β pathway. In conclusion, glucocorticoids induced the myofibroblast transdifferentiation in TMCs, which played a crucial role in the pathogenesis of GIG. Inhibition of ARHGEF26 expression protected TMCs by reversing myofibroblast transdifferentiation. This study demonstrated the potential of reversing the myofibroblast transdifferentiation of TMCs as a new target for treating GIG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Min Zhu, Xizhi Deng, Nan Zhang, Pengyu Zhang, Cheng Lai, Shuncheng Cai, Jingqiu Huang, Xiaomin Chen, Yang Liu, Wen Zeng, Min Ke
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, M., Deng, X., Zhang, N., Zhang, P., Lai, C., Cai, S., Huang, J., Chen, X., Liu, Y., Zeng, W., & Ke, M. (2024). Dexamethasone induces trabecular meshwork cell myofibroblast transdifferentiation through ARHGEF26. The FASEB Journal. https://doi.org/10.1096/fj.202400400rr
Vancouver
Zhu M, Deng X, Zhang N, Zhang P, Lai C, Cai S, et al. Dexamethasone induces trabecular meshwork cell myofibroblast transdifferentiation through ARHGEF26. The FASEB Journal. 2024. doi:10.1096/fj.202400400rr
BibTeX
@article{Zhu2024,
author = {Zhu, Min and Deng, Xizhi and Zhang, Nan and Zhang, Pengyu and Lai, Cheng and Cai, Shuncheng and Huang, Jingqiu and Chen, Xiaomin and Liu, Yang and Zeng, Wen and Ke, Min},
title = {Dexamethasone induces trabecular meshwork cell myofibroblast transdifferentiation through ARHGEF26},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202400400rr}
}
EUVIMED